Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The vascular patches market is expected to reach USD 525.8 million by 2023 from USD 349.6 million in 2018, at a CAGR of 8.5%

ReportBuyer
Posted on: 28 Jun 18
The vascular patches market is expected to reach USD 525.8 million by 2023 from USD 349.6 million in 2018, at a CAGR of 8.5%

PR Newswire

LONDON, June 28, 2018

LONDON, June 28, 2018 /PRNewswire/ -- Vascular Patches"The global vascular patches market is projected to grow at a CAGR of 8.5% during the forecast period.

Download the full report: https://www.reportbuyer.com/product/5440304

The vascular patches market is expected to reach USD 525.8 million by 2023 from USD 349.6 million in 2018, at a CAGR of 8.5%. Factors such as rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases; increasing number of vascular surgeries performed; and increasing adoption of biological patches are driving the growth of the market. The decreasing number of carotid endarterectomy surgeries and product failures and recalls are expected to limit market growth in the coming years.

The biologic vascular patch segment is estimated to grow at the fastest rate in the next five years.

On the basis of material, the vascular patches market is segmented into biologic vascular patches and synthetic vascular patches.The biologic vascular patches segment is expected to grow at the highest CAGR during the forecast period.

Growth in this market can largely be attributed to the advantages associated with the use of biologic vascular patches, such as superior biocompatibility, ease of use, minimal suture line bleeding, and reduced rates of infection in comparison with synthetic patches.

Asia Pacific is estimated to grow at the highest CAGR during the study period.

Geographically, the vascular patches market is dominated by North America, followed by Europe in 2017.However, Asia Pacific is estimated to grow at the fastest rate due to the rising prevalence of cardiovascular diseases and the implementation of favorable government initiatives in several Asian countries.

In India, for example, the central government and the Health Ministry launched the AMRIT (Affordable Medicines & Reliable Implants for Treatment) program in 2015, which enables pharmacies in government hospitals to sell various devices, cardiac implants, and cardiovascular drugs at 50–60% lower prices. Such initiatives will help boost the demand for cardiac products, including vascular patches, in the coming years.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1–35%, Tier 2–22% and Tier 3- 43%
• By Designation: C level–15%, Director level–32%, Others–53%
• By Region: North America–34%, Europe–25%, Asia Pacific–23%, Rest of the World–18%

The key players in the vascular patches market include Terumo Corporation (Japan), C.R.

Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).

Research Coverage:
The report analyses the vascular patches market by material, application, end user, and region.Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years.

In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.

Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the vascular patches market
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the vascular patches market
• Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the vascular patches market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vascular patch products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular patches market

Download the full report: https://www.reportbuyer.com/product/5440304

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-vascular-patches-market-is-expected-to-reach-usd-525-8-million-by-2023-from-usd-349-6-million-in-2018--at-a-cagr-of-8-5-300674024.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 28/06/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.